刘晚生

美中医药开发协会 候任会长 福克斯?罗斯柴尔德 律师事务所 合伙人和中国业务主席

Wansheng Jerry Liu, Ph.D., J.D., is a Partner and the Chair of China Practice Group at Fox Rothschild LLP, a 900-lawyer U.S. law firm. Jerry practices in wide areas of Intellectual Property and Corporate laws, including patent and trademark prosecution, litigation, legal opinions, contract review, formation of business entities, non-profit organizations, etc., and has handled due diligence for numerous M&A, investment, and licensing deals valued from multi-million to multi-billion dollars.

Prior to law practice, Jerry had over a decade of working experiences, including working as an Assistant Engineer at the Yizheng Joint Corporation of Chemical Fibre Industry, now a subsidiary of Sinopec, for two years and as a Senior Research Investigator in process development at Bristol-Myers Squibb Company for eight years. Jerry obtained Ph.D. in Organic Chemistry with Professor Sir Derek H. R. Barton (Nobel Prize, 1969) from Texas A&M University, J.D. from Rutgers University School of Law, and B.S./M.S. in Chemistry/Polymer Science from University of Science and Technology of China (USTC).

In law school, Jerry served as the Editor-in-Chief of Rutgers Law Record and the Executive Board members of Rutgers Business Law Journal and Rutgers Conflict Resolution Law Journal. Jerry currently serves as the President-Elect of Sino-American Pharmaceutical Professionals Association (SAPA), a Co-Chair of the China National Intellectual Property Administration (CNIPA) Committee of the New York Intellectual Property Law Association (NYIPLA), and the General Counsel of the USTC Alumni Association of Greater New York. A frequent speaker on IP laws and FDA regulations, Jerry has over 20 scientific and legal publications and is an inventor to four U.S. patents.